TD Asset Management Inc Raises Position in The Cooper Companies, Inc. $COO

TD Asset Management Inc increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 17.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 804,609 shares of the medical device company's stock after buying an additional 118,411 shares during the quarter. TD Asset Management Inc owned 0.40% of Cooper Companies worth $57,256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. increased its holdings in shares of Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after acquiring an additional 686,751 shares in the last quarter. Millennium Management LLC grew its position in Cooper Companies by 36.0% during the 1st quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company's stock worth $217,405,000 after purchasing an additional 682,166 shares during the last quarter. Nuveen LLC acquired a new position in Cooper Companies during the 1st quarter valued at approximately $55,367,000. Alecta Tjanstepension Omsesidigt raised its holdings in shares of Cooper Companies by 60.7% in the second quarter. Alecta Tjanstepension Omsesidigt now owns 1,349,500 shares of the medical device company's stock worth $96,030,000 after buying an additional 509,800 shares during the last quarter. Finally, Select Equity Group L.P. raised its holdings in shares of Cooper Companies by 185.0% in the first quarter. Select Equity Group L.P. now owns 749,050 shares of the medical device company's stock worth $63,182,000 after buying an additional 486,241 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Cooper Companies

In other news, COO Daniel G. Mcbride acquired 3,000 shares of the firm's stock in a transaction on Tuesday, September 2nd. The stock was acquired at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the transaction, the chief operating officer owned 63,120 shares in the company, valued at approximately $4,105,324.80. The trade was a 4.99% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Albert G. White III bought 10,000 shares of the stock in a transaction dated Friday, September 5th. The shares were purchased at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the purchase, the chief executive officer owned 226,151 shares in the company, valued at approximately $15,466,466.89. This represents a 4.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 17,975 shares of company stock valued at $1,216,346 in the last quarter. 1.98% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on COO shares. Morgan Stanley set a $76.00 target price on Cooper Companies and gave the company an "equal weight" rating in a research report on Thursday, August 28th. Stifel Nicolaus cut their price objective on Cooper Companies from $90.00 to $85.00 and set a "buy" rating on the stock in a report on Thursday, August 28th. Needham & Company LLC restated a "buy" rating and issued a $94.00 price objective on shares of Cooper Companies in a research note on Thursday, August 28th. Robert W. Baird dropped their target price on Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a research report on Thursday, August 28th. Finally, Barclays started coverage on shares of Cooper Companies in a report on Monday. They issued an "overweight" rating and a $85.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and a consensus target price of $84.77.

Cooper Companies Stock Down 3.4%

Cooper Companies stock opened at $68.76 on Thursday. The business's 50-day moving average price is $69.43 and its 200 day moving average price is $73.43. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The firm has a market cap of $13.67 billion, a price-to-earnings ratio of 33.87, a price-to-earnings-growth ratio of 1.87 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $109.04.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has authorized a stock buyback program on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its stock is undervalued.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.